Kinnevik led a $220m Series D round in Oviva.

Kinnevik, a Swedish investment company, led a $220m Series D round in Oviva, a provider of digital, reimbursed care for weight-related and chronic conditions, with participation from Planet First Partners, A.P. Moller Holding, Lunate, EGS Beteiligungen, Norrsken VC, and Sofina. The financing will support Oviva in meeting growing demand, expanding into additional markets and chronic conditions such as hypertension and type 2 diabetes, as well as further advancing several AI initiatives.